Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.02M P/E - EPS this Y - Ern Qtrly Grth -
Income -90.54M Forward P/E -0.06 EPS next Y - 50D Avg Chg -49.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -88.00%
Dividend N/A Price/Book 0.03 EPS next 5Y - 52W High Chg -98.00%
Recommedations 3.00 Quick Ratio 1.45 Shares Outstanding 26.09M 52W Low Chg 22.00%
Insider Own 12.20% ROA -32.24% Shares Float 23.94M Beta 1.95
Inst Own 0.02% ROE -124.56% Shares Shorted/Prior 447.72K/164.41K Price 0.04
Gross Margin - Profit Margin - Avg. Volume 4,700,583 Target Price -
Oper. Margin - Earnings Date Mar 22 Volume 20,361 Change 0.00%
About Oncorus, Inc.

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.

ONCR Chatroom

User Image jhalawar Posted - 4 months ago

$ONCR I use fidelity.. and do not see dividends yet. Anyone else? With any broker?? You received dividends?

User Image gwinters Posted - 4 months ago

@Gar_una I don't think it is corrupt at all. Most biotech companies spend everything and go negative before calling it quits. $ONCR executives and board had the guts to call it quits while there was still something left. I give them kudos for that. Biotech research companies are a gamble. Some hit it big. Most fail. Running a research company that doesn't work out doesn't make someone corrupt.

User Image Stunker99 Posted - 4 months ago

$ONCR I own 18000 shares on my swedish bank Avanza, and have'nt received any dividend. Anyone else in similar situation?

User Image Miok Posted - 4 months ago

$ONCR mother fker, Do I see 0.20 after hour?!

User Image tactictrade Posted - 12/29/23

$ONCR Congrats to folks who bought for less than 10 cents. You guys made good trade and profit. I sold 500k shares at 0.01 a couple of days back. Feeling very sad that I couldn’t hold till end of December. Anyway god should have other plans for me or that’s what my luck is

User Image JohanDeWitte Posted - 12/29/23

$ONCR payout is $0.1393/sh. •Payment date December 29, 2023 •Record date December 27, 2023 •Ex-dividend date January 2, 2024

User Image vu_jade Posted - 12/28/23

$ONCR any chance this goes back to $10?

User Image inastok Posted - 12/28/23

$ONCR big whales covering ehile trading in retail cannot buy nor sell, its gamestock all over

User Image Stunker99 Posted - 12/28/23

$ONCR Too bad my swedish broker wont let me sell this, almost at break even...

User Image vu_jade Posted - 12/28/23

$ONCR monster squeeze coming ?

User Image gwinters Posted - 12/28/23

@Miok Huh? Totally false. $ONCR has no employees, no products, no CEO, and no board. It's just an accounting firm overseeing the liquidation. $CCCC isn't the same at all.

User Image Miok Posted - 12/27/23

$ONCR $CCCC both run by same people

User Image vu_jade Posted - 12/27/23

$ONCR what’s up,with this bitch? Don’t they have like 20-30c in cash?

User Image Miok Posted - 12/27/23

$ONCR shorts are covering when no one is paying attention. criminal at its best.

User Image Miok Posted - 12/27/23

$ONCR im cry if this hits .20 cent rip short selling covering

User Image Miok Posted - 12/27/23

$ONCR 592% wish i had the gut to load more at the bottom.

User Image Miok Posted - 12/27/23

$ONCR finally. out at 0.09. that hold for months.

User Image tactictrade Posted - 5 months ago

$ONCR almost at the end of tax year. Wondering if they will Payout within this tax year/ this month end or drag it into next year

User Image gwinters Posted - 11/22/23

@tactictrade I wouldn't read too much into it. My broker shows 2,166 shares traded. That means the pop was caused by someone spending $93 on $ONCR without paying attention to price.

User Image tactictrade Posted - 11/21/23

$ONCR Nice 100% pop. Something is brewing. We might be close to distribution date

User Image GapTradingGuy Posted - 6 months ago

$OMGA - Omega Therapeutics encountered a common gap down today, opening at a slight -0.55% from yesterday's close. The gap didn't present a significant hurdle, as it has been 100% backfilled today, with the current price hovering just below the target price. While today isn't the optimal day for gap fills for Omega, as Friday holds that title, the quick recovery today is a positive sign. With the gap already filled, the odds of it being filled today are moot, but were a favorable 80%. Looking ahead, the chances of a gap fill within the next five days remain high at 79%, although any further trading on this gap is no longer on the table. For traders eyeing that 0.5%-1% profit margin, Omega Therapeutics could have been a viable candidate today. As the gap has been completely closed, future odds should be considered in retrospect. With a general likelihood of any gap fill at 70%, Omega has shown it can quickly bounce back from minor setbacks. $OMND-CA $ONCR $ONCSQ.

User Image GapTradingGuy Posted - 6 months ago

$SLS - SELLAS Life Sciences Group has experienced a full gap down today of -4.12%, a significant move that could signal a continuation of the trend. With a robust 75% of the gap already backfilled and the current price just a penny shy of yesterday's close, the stock shows strong momentum. The odds of the gap being filled today stand at a confident 77%, well above the threshold for considering a trade. Given that it's Wednesday, we're a bit off from the best day for gap fills, which is Monday for SLS, but the stats still favor a complete fill within the five-day window at 85%. For gap traders aiming for that 0.5%-1% profit sweet spot, SLS is exhibiting promising potential, especially with an overall 72% likelihood of the gap filling at some point. Keep an eye on the peers for related momentum: $OMGA $OMND-CA $ONCR.

User Image GapTradingGuy Posted - 6 months ago

$DNA - Ginkgo Bioworks opened the Tuesday session with a common gap down of -1.32% from the previous close of $1.52. True to form for Tuesdays, the stock has effectively backfilled the gap, rallying to a high of $1.63. Since the gap has been filled completely today, the initial odds of 76% for the gap closing today have now shifted into past performance. With the current price at $1.55, slightly above the opening of $1.50, Ginkgo Bioworks shows a strong intraday recovery. While the odds for the gap filling within the next five days stood at 74%, and at 70% anytime, these figures are less immediate but still indicate a likelihood of similar movements in the near future. For gap traders who generally target a 0.5% to 1% profit, today's activity would have been right on target. Now, any further trading strategies will be looking beyond the gap fill. $OMGA $OMND-CA $ONCR

User Image tactictrade Posted - 6 months ago

$ONCR Who all still waiting here to receive dissolution payout?

User Image catpoop Posted - 10/27/23

$ONCR looks cheap

User Image TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $ONCR Oncorus will be reporting on 11/06/2023 at 7:00AM | Will earnings beat estimates or miss the mark?

User Image tactictrade Posted - 10/21/23

$ONCR Here is what I found. It appears some of their patents are sold. With this, I’m hopeful to get distribution cash. Let’s see how much we get paid @Proto_Man @gwinters

User Image tactictrade Posted - 7 months ago

$ONCR Guys any update on where the dissolution is at? I don’t see a SEC filing recently about stockholders approving dissolution plan or next steps in distribution. I also notice a yield symbol in OTC website with a grace period status. Fingers crossed 🤞

User Image Rampageusa Posted - 09/19/23

There is always a bull market somewhere - $CHNR,$MEGL,$SCNI,$ONCR,$OMH...Go bulls..

User Image gwinters Posted - 8 months ago

$ONCR Don't expect to hear anything right away. The last auction of lab equipment doesn't end until October 13th: https://ssllc.com/auction/Sale-3-State-of-The-Art-Bioprocessing-and-Lab-Equipment-Formerly-of-Oncorus

Analyst Ratings
HC Wainwright & Co. Neutral Dec 6, 22
Chardan Capital Neutral Dec 1, 22
Chardan Capital Buy Jun 15, 22
Piper Sandler Overweight May 19, 22
HC Wainwright & Co. Buy Mar 28, 22
Maxim Group Buy Mar 16, 21
Jefferies Buy Oct 27, 20
Piper Sandler Overweight Oct 27, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Flynn James E - - Dec 28 Sell 0.26 336,235 87,421 284,697 12/30/22
Flynn James E - - Dec 22 Sell 0.28 73,384 20,548 321,551 12/27/22
Flynn James E - - Dec 19 Sell 0.3 128,258 38,477 329,596 12/21/22
Flynn James E - - Dec 13 Sell 0.39 13,786 5,377 343,655 12/15/22
Wanstall Rick CFO and Treasurer CFO and Treasurer May 25 Buy 1.20 3,777 4,532 51,000 05/25/22
Wanstall Rick CFO and Treasurer CFO and Treasurer May 20 Buy 1.20 1,610 1,932 47,223 05/24/22